policy

US Food and Drug Administration regulatory reviewer disagreements and postmarket safety actions among new therapeutics
Ashley Eadie, Andrea MacGregor, Joshua Wallach, Joseph Ross, Matthew Herder

BMJ Evidence-Based Medicine Jun 2023, 28 (3) 151-156; DOI: 10.1136/bmjebm-2022-112005
Using individual participant data to improve network meta-analysis projects
Richard D Riley, Sofia Dias, Sarah Donegan, Jayne F Tierney, Lesley A Stewart, Orestis Efthimiou, David M Phillippo

BMJ Evidence-Based Medicine Jun 2023, 28 (3) 197-203; DOI: 10.1136/bmjebm-2022-111931
FDA’s dilemma with the aducanumab approval: public pressure and hope, surrogate markers and efficacy, and possible next steps
John G Rizk, John C Lewin

BMJ Evidence-Based Medicine Apr 2023, 28 (2) 78-82; DOI: 10.1136/bmjebm-2022-111914
Improving FDA postmarket adverse event reporting for medical devices
Susmitha Wunnava, Timothy A Miller, Florence T Bourgeois

BMJ Evidence-Based Medicine Apr 2023, 28 (2) 83-84; DOI: 10.1136/bmjebm-2021-111870
Consistency between trials presented at conferences, their subsequent publications and press releases
Anisa Rowhani-Farid, Kyungwan Hong, Mikas Grewal, Jesse Reynolds, Audrey D Zhang, Joshua D Wallach, Joseph S Ross

BMJ Evidence-Based Medicine Apr 2023, 28 (2) 95-102; DOI: 10.1136/bmjebm-2022-111989
Guest authorship as research misconduct: definitions and possible solutions
E H Morreim, Jeffrey C Winer

BMJ Evidence-Based Medicine Feb 2023, 28 (1) 1-4; DOI: 10.1136/bmjebm-2021-111826
'Is there racism in academic medical publishing?’
Madunil Anuk Niriella, Arjuna Priyadarshin De Silva, Hithanadura Janaka de Silva, Saroj Jayasinghe

BMJ Evidence-Based Medicine Dec 2021, 26 (6) e3; DOI: 10.1136/bmjebm-2020-111487
When we move cancer drugs from the second or third to the first line of treatment: what lessons can we learn from KEYNOTE-177 and JAVELIN-100
Myung S Kim, Vinay Prasad

BMJ Evidence-Based Medicine Jun 2022, 27 (3) 151-152; DOI: 10.1136/bmjebm-2021-111702
From publication bias to lost in information: why we need a central public portal for clinical trial data
Beate Wieseler, Natalie McGauran

BMJ Evidence-Based Medicine Apr 2022, 27 (2) 74-76; DOI: 10.1136/bmjebm-2020-111566
Maternal caffeine consumption and pregnancy outcomes: a narrative review with implications for advice to mothers and mothers-to-be
Jack E. James

BMJ Evidence-Based Medicine Jun 2021, 26 (3) 114-115; DOI: 10.1136/bmjebm-2020-111432

Main menu

policy

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

policy

Pages